arrow
H

Heather Friberg

takeda pharmaceuticals international inc
H指数:19
被引数:1,263

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Humoral and cellular responses to a tetravalent dengue vaccine (TAK-003) in adults from a dengue non-endemic region: An open-label phase 2 trial

对来自非登革热流行区的成人接种四价登革热疫苗(TAK-003)后的体液和细胞免疫反应:一项开放标签二期临床试验

Vaccine
IF3.5
2026-04-020
OAAI
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1trial
2024-08-014
PRE
Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular Cytotoxicity

NS1-Specific抗体通过抗体依赖性细胞毒性在对登革热病毒的免疫反应中的保护作用

2024-03-132
PRE
Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial
2020-09-2318
OAAI
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques
2020-04-0819
OAAI